Signe Munk

Signe Munk currently serves as Vice President at Ferrosan Medical Devices, leading New Business Development and overseeing the Project Execution Unit since February 2019. Prior to this role, Signe was Group Vice President at Hempel A/S, where leadership spanned global R&D efforts across 15 centers with over 300 employees. During tenure at Novozymes from March 2013 to June 2016, Signe held the position of Vice President for R&D, being responsible for Animal Health and Nutrition, and also directed the global Toxicology and Regulatory Affairs function. Signe founded Cofactor Group ApS in 2012, a consulting firm focused on innovation strategy and leadership. Earlier career phases included roles at Novozymes where Signe progressed from Scientist to Director in Detergent Research, emphasizing innovation and strategic partnerships. Signe holds a Ph.D. in Applied Enzymology and an M.Sc. in Chemical Engineering from the Technical University of Denmark, complemented by specialized business development training from IMD.